Amarasate® Weight Loss Study: Significant Fat L...
A 24-week double-blind RCT in 150 overweight adults: Calocurb® significantly reduced fat and visceral fat while preserving lean muscle mass.
The Link Between Obesity and Men’s Mental Healt...
Men's mental health and obesity are more closely linked than many realize. Almost 40% of American men are obese, significantly raising their risk of depression and other psychiatric conditions.
Why Weight Regain Happens After GLP-1s and Weig...
Rebound Weight Gain After Weight Loss: Why it Occurs and How to Prevent It. It's long been known that deliberate weight loss is typically followed by rebound weight gain unless...
From Farm to Capsule: The Story Behind Calocurb...
Calocurb's key ingredient, Amarasate®, starts its journey on a New Zealand hop farm. Discover the science, sustainability, and story behind every capsule.
Acknowledging Gender Differences in Obesity Res...
It’s timely to review the differences in women’s health research and how that specifically affects investigations into treatments for overweight and obesity. Obesity and overweight—gender similarities and differences By 2022,...
How Calocurb Supports Patients Using GLP-1 Medi...
Calocurb's plant-based Amarasate® extract stimulates gut hormones that reduce hunger — making it a practical tool alongside GLP-1 receptor agonists at every stage of treatment.
Oral Wegovy Explained: OASIS-4 Results, Side Ef...
The Wegovy pill launched in the US in early January 2026, reaching 18,000 prescriptions in its first week. Here's how the science compares to Calocurb.
Helping Patients Stay Consistent: Satiety Suppo...
Early-year motivation fades fast when hunger takes over. Learn how supporting satiety biology can help your patients stay on track long after January.
Smart, Simple Ways to Help Patients Eat Less Th...
The holiday season makes healthy habits hard to maintain — but with the right strategies, your patients can enjoy every celebration without losing control of their choices.
Managing weight gain in perimenopause and menop...
Perimenopause triggers hormonal shifts that drive weight gain, increased appetite, and changes in body composition — but understanding the science can help women take control.
Managing PCOS Eating Behaviors
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting reproductive women, affecting 10-13% of females, including adolescents to post-menopausal women.1 Despite its preponderance, globally women report delayed diagnosis...
Support Patients to Build a Calocurb Habit Daily
Helping patients stay consistent with Calocurb comes down to smart habit design. These four practical strategies make daily use feel automatic.
Optimizing Protein Intake for Muscle Preservati...
As healthcare professionals working with patients seeking weight loss, you’ve likely encountered the frustrating scenario: a patient diligently follows a calorie-restricted diet, loses weight initially, then hits a plateau despite...
How Calocurb Practitioners Can Use AI to Suppor...
Nourish Together AI makes meal tracking effortless for patients — just snap a photo and get thoughtful, non-judgmental food reflections to support their journey.
Is Calocurb Safe? Natural GLP-1 Support Explained
GLP-1 injectable drugs work but come with real side effects. Calocurb offers a natural, well-tolerated alternative that supports your body's own GLP-1 production.
Managing Premenstrual Food Cravings
In recent years there has been a surge in the discussions around perimenopause/menopause and how the fluctuation and eventual depletion of sex hormones contribute to changes in appetite and body...
Berberine and Akkermansia for Weight Loss — How...
Compare Berberine, Akkermansia, and Calocurb for weight loss. Learn about their effects on GLP-1, appetite, and body metrics, plus insights on safety, studies, and unique benefits.
Amarasate - The Active Ingredient In Calocurb: ...
GLP-1 receptor agonists are reshaping obesity treatment, but how do they compare to natural GLP-1 stimulants like Amarasate®? A clinical look at the science behind both approaches.
Rebound Weight Gain After Weight Loss: Why It O...
Stopping GLP-1 medications like semaglutide or tirzepatide often leads to rapid weight regain. Science explains why — and a natural alternative may help.
Women Are Not Small Men—Especially When It Come...
Women and men differ in obesity rates, food cravings, and how they respond to weight loss treatments — yet most research still treats the male body as the default.
Managing Weight Gain in Perimenopause and Menop...
Up to 70% of women gain weight during perimenopause — and it's not just lifestyle. Falling estrogen directly drives appetite, fat storage, and metabolic slowdown.
